Sapacitabine Phase II results
Now the first results from trials with Sapacitabine are presented: In the ongoing MDS stratum thus far 31 patients aged above 60 years have been treated with Sapacitabine as second line therapy following treatment with hypomethylating agents. Complete remission and hematological improvement have been observed in 7 patients.
|All times are GMT -4. The time now is 02:55 AM.|
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2020, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org